Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,658.00    0.00 (0.00%)
Bid:
1,656.00
Ask:
1,664.00
Spread: 8.00 (0.483%)
Market Cap: £488.31m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Contract delay and trading update

17 Dec 2020 07:00

RNS Number : 9247I
Avon Rubber PLC
17 December 2020
 

17 December 2020

Avon Rubber p.l.c.

Contract delay and trading update

Avon Rubber p.l.c. ("Avon Rubber" or "the Group") today provides an update on the ballistic protection contracts within its Military business together with an update on Group trading for the financial year ending 30 September 2021 ("FY21").

 

Contract delay

 

Following the awards of contracts for the U.S. Defense Logistics Agency Enhanced Small Arms Protective Inserts ("DLA ESAPI") and U.S. Army Vital Torso Protection ("VTP") body armor plates, we have been engaged with these customers to complete the necessary product approval processes, which had been expected to conclude in the first half of FY21. Disappointingly, these approval processes have been delayed as a result of a failure encountered in First Article Testing. Whilst we remain confident of completing these processes and are working with our customers to expedite the approvals, this initial delay means that first deliveries under these contracts are now expected to commence in the first half of our 2022 financial year.

Separately, we have been notified that a protest has been made against the U.S. Army Next Generation Integrated Head Protection System sole source contract announced on 24 September 2020. Whilst the delay created by this protest is unwelcome, its outcome is not currently expected to have any material impact on Group expectations for FY21.

Trading update

 

Further to the update provided alongside the 2020 full year results on 2 December 2020, trading has continued as expected in the first quarter of FY21, with good order intake across our portfolio of life critical personal protection systems for the world's militaries and first responders.

 

Within the Military business, we have received the first orders under the NATO Support & Procurement Agency Contract totalling $33 million as separately announced today. Follow-on orders have also been received from the U.S. Department of Defense ("U.S. DOD") under the M53A1 mask and powered air system contract in addition to continued strong demand for spares and accessories from the U.S. DOD and Rest of World Military customers. We expect to receive further follow-on orders under our long-term U.S. DOD contracts during the first half of the 2021 financial year.

 

Team Wendy has performed well and in line with expectations in the first month of ownership, with strong order intake including follow-on ballistic helmet orders from the Australian Defence Force.

Within our First Responder business, we have continued to see strong COVID-19 related demand across our entire respiratory protection range. We have also continued to see encouraging progress in pipeline building and order intake for the Ceradyne ballistic helmet range following its launch in North America in July 2020.

Consequently, whilst the delay in first deliveries under the DLA ESAPI and VTP body armor contracts described above will reduce overall expectations for FY21, the Board remains confident in achieving its medium-term expectations given the momentum we are seeing across the business.

Commenting, Paul McDonald, Chief Executive Officer, said:

 

"We are working collaboratively with our customers to resolve the delays to product approval for the DLA ESAPI and VTP contracts as quickly as possible. These contracts remain an important part of the ballistic protection portfolio and will be a significant contributor to the Group over the medium term.

 

The business continues to perform strongly, and our 2021 financial year will see further significant progress as a result of continued growth as well as the contribution from the recent Team Wendy acquisition. We remain very confident in the Group's medium-term prospects which are built on a strong, growing and visible contract pipeline, together with a clear strategy."

 

For further enquiries, please contact:

 

Avon Rubber p.l.c.

 

Paul McDonald, Chief Executive Officer

01225 896 848

Nick Keveth, Chief Financial Officer

 

Ryan Mahoney, Deputy Chief Financial Officer

 

 

 

MHP Communications

 

Andrew Jaques

0203 128 8570

Charlie Barker

avonrubber@mhpc.com

Pete Lambie

 

Legal Entity Identifier: 213800JM1AN62REBWA71

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Note to editors: 

Avon Rubber is listed on the London Stock Exchange (LSE: AVON) and is a constituent of the FTSE 250 Index.

Avon Rubber is an innovative technology group, which designs and produces life critical personal protection systems to maximise the performance and capabilities of its customers, with leading positions in the respiratory and ballistic protection markets for the world's militaries and first responders.

For further information, please visit our website: www.avon-rubber.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPGBCPUPUGRQ
Date   Source Headline
13th May 20267:00 amRNSInterim Results
8th May 20267:00 amRNSHolding(s) in Company
6th May 20262:03 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSHolding(s) in Company
14th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Apr 202612:15 pmRNSHolding(s) in Company
8th Apr 202611:47 amRNSDirector/PDMR Shareholding
27th Mar 20261:23 pmRNSDirector/PDMR Shareholding
6th Mar 20261:23 pmRNSDirectors'/PDMR Shareholdings
6th Mar 20267:00 amRNSNew Filter Order
3rd Mar 20262:34 pmRNSHolding(s) in Company
13th Feb 202611:01 amRNSDirector/PDMR Shareholding
6th Feb 20262:52 pmRNSDirectors'/PDMR Shareholdings
6th Feb 20262:41 pmRNSFinal Dividend Currency Exchange Rate
4th Feb 20264:18 pmRNSHolding(s) in Company
2nd Feb 202610:10 amRNSResult of AGM
30th Jan 20267:00 amRNSAGM & Q1 Trading Update
20th Jan 20263:19 pmRNSDirector/PDMR Shareholding
6th Jan 20261:46 pmRNSDirectors'/PDMR Shareholdings
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
16th Dec 20258:45 amRNSHolding(s) in Company
11th Dec 20253:51 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSEuropean FM50 Order
9th Dec 202511:58 amRNSDirectors'/PDMR Shareholding
8th Dec 20251:32 pmRNSDirectors'/PDMR Shareholdings
5th Dec 20259:00 amRNSNotice of Annual Report & Accounts and AGM 2026
1st Dec 20256:01 pmRNSDirector Declaration
25th Nov 20253:55 pmRNSHolding(s) in Company
21st Nov 20259:50 amRNSNotification of LTIP & DSBP Awards
12th Nov 20257:00 amRNSPreliminary Results
7th Nov 20259:23 amRNSDirectors'/PDMR Shareholdings
16th Oct 20257:00 amRNSNotice of Results & Investor Presentation via IMC
8th Oct 202510:06 amRNSDirectors'/PDMR Shareholding
15th Sep 20252:51 pmRNSHolding(s) in Company
11th Sep 20254:10 pmRNSHolding(s) in Company
8th Sep 20251:14 pmRNSDirectors'/PDMR Shareholding
13th Aug 20254:59 pmRNSInterim Dividend Currency Exchange Rate
11th Aug 20254:47 pmRNSHolding(s) in Company
7th Aug 20253:10 pmRNSDirectors'/PDMR Shareholdings
17th Jul 20257:00 amRNSDirectors'/PDMR Shareholdings
23rd Jun 20257:00 amRNSUK MoD respirator order for Ukraine
10th Jun 20257:00 amRNSHolding(s) in Company
9th Jun 20259:30 amRNSDirectors'/PDMR Shareholdings
5th Jun 20253:31 pmRNSUS Department of Defense Order
3rd Jun 20256:00 pmRNSRenewi
29th May 202510:00 amRNSHolding(s) in Company
21st May 20257:00 amRNSInterim Results
20th May 20254:00 pmRNSNotification of change in particulars of director
16th May 20253:00 pmRNSNotification of change in particulars of director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.